Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

510(k) for Chiron Diagnostics:

This article was originally published in Clinica

Executive Summary

Chiron Diagnostics has received FDA clearance for its ACS:180 Troponin I assay. The fully-automated cardiac marker measures the quantity of troponin I, one of the three polypeptides which make up the cardiac troponin complex (cTnl), in serum and plasma. cTnl is not normally found in circulation and any level of this complex in the blood indicates some form of myocardial damage.

Topics

UsernamePublicRestriction

Register

MT081091

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel